Aminoacyl tRNA synthetase inhibitors are designed to interfere with the enzyme's ability to bind to its substrates (amino acid, ATP, or tRNA). These inhibitors can be competitive or non-competitive and are used to disrupt protein synthesis in pathogens. For instance, mupirocin targets the isoleucyl-tRNA synthetase in bacteria, making it an effective antibiotic.
